Allelica’s PREDICT module is a resource for clinical laboratories and healthcare providers to generate personalized PRS reports for common diseases. The end-to-end solution starts with patient genotype data generated from microarray or lcWGS technology. Users can then choose from a range of diseases to report on, including coronary artery disease, breast cancer, and Alzheimer’s disease. In just a few hours, the platform applies Allelica’s predictive analytics to calculate individual genetic risk scores for the diseases of interest. The technology accounts for a patient’s ancestry by comparing the risk scores to a distribution matched to the individual’s ancestry. The resulting report communicates the individual’s genetic risk of disease in a concise and comprehensible document.

Allelica has created a secure and trusted platform for Polygenic Risk Score analysis and reporting to equip health systems and clinical laboratories with cutting-edge tools to reduce the impact of common disease through genomic medicine. 

All processes performed on the Allelica platform are fully HIPAA and GDPR-compliant. ISO 13485 and ISO 9001 certifications guarantee that Allelica applies medical device quality management processes every step of the way.

Allelica is working with leading health systems and genetics laboratories in the United States and across Europe to advance disease prevention through widened application of PRS in healthcare.

The UDoTest in-home delivery platform was designed to close screening gaps and to serve your patients with a unique at-home screening experience, that's supported by labs and physicians and focuses on high cost, high-risk diseases.

If closing screening gaps, improving your patient engagement, and improving HEDIS quality is a need for you, then our UDoTest platform is your solution. UDoTest's at-home delivery platform was designed to close screening gaps, and to activate a unique at-home screening experience for your patients. Our sophisticated platform and service was designed specifically for providers, and works with their laboratories and physicians, while focussing on high cost, high-risk diseases. We're currently working with leading providers and health plans across the country on their cancer, diabetes screening and quality gaps to name a few.